Florida-based Earth Science Tech (OTCQB: ETST), a biotechnology company offering high-grade cannabinoids, holds a portfolio of diverse subsidiaries, including Earth Science Pharmaceutical Inc., Cannabis Therapeutics Inc. and Canna Inno Laboratories Inc., that support the company’s position as a leader in the CBD sector. A recent article discussing the company reads, “Wholly owned subsidiary Earth Science Pharmaceutical develops low-cost, noninvasive diagnostic tools, medical devices, testing processes and vaccines for sexually transmitted infections and diseases (STIs). The executive team of Earth Science Pharma has years of scientific, medical and business experience in the health, research and manufacturing fields. The subsidiary is working to develop and bring to market medical devices and vaccines that meet the specific needs of women.”
To view the full article, visit http://cnw.fm/MSTc4
About Earth Science Tech Inc.
Earth Science Tech offers the highest purity and quality high-grade, full-spectrum cannabinoid oil on the market. Studies by DV Biologics prove the company’s CBD oil formulation lowers cortisol and functions as a neuroprotectant, with positive-result case studies through key health organizations. ETST formulates, markets and distributes the CBD oil used for these studies to the public, offering the most effective quality of CBD on the market. For more information, visit the company’s website at www.EarthScienceTech.com.
NOTE TO INVESTORS: The latest news and updates relating to ETST are available in the company’s newsroom at http://cnw.fm/ETST
CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.
To receive instant SMS alerts, text CANNABIS to 21000
For more information please visit https://www.CannabisNewsWire.com
Do you have a questions or are you interested in working with CNW? Ask our Editor